CannaMD

MARCH 3, 2021

Law enforcement, policy makers, and public citizens have long debated how recreational marijuana legalization influences crime and public safety. Journal of Economic Analysis & Policy , and PLOS One – discovering a buffer effect and decreased crime rates. Most existing research focuses on crime in legalized states.

Legalization 119

Legalization Marijuana Data Safety 119

Peninsula Alternative Health

MARCH 1, 2018

Check out this comprehensive list by Peninsula Alternative Health in Salisbury, Maryland: Americans for Safe Access (ASA). based nonprofit and Americans for Safe Access Foundation “share the mission of ensuring safe and legal access to cannabis.for therapeutic use and research,” according to its website. This Washington, D.C.-based

Treatment 40

Treatment Education Advocacy Access 40

Peninsula Alternative Health

MARCH 1, 2018

Check out this comprehensive list by Peninsula Alternative Health in Salisbury, Maryland: Americans for Safe Access (ASA). based nonprofit and Americans for Safe Access Foundation “share the mission of ensuring safe and legal access to cannabis.for therapeutic use and research,” according to its website. This Washington, D.C.-based

Treatment 40

Treatment Education Advocacy Access 40

Veriheal

MARCH 29, 2023

In addition, several other studies suggest that legalizing access to marijuana is actually associated with decreased: Crime Opioid overdose Mental illness rates Gone are the days when cautionary tales run rampant. How Several Sources of Data Were Used in the Research In 2019, an estimated 48.2 1, 2003, to Dec. 1, 2003, to Dec.

Legalization 57

Legalization Data Policy Cannabis 57

Veriheal

JUNE 30, 2023

A study investigated psilocybin’s effect on alcohol addiction, the FDA outlined best practices for future psychedelic research, and the NCAA is inching toward cannabis policy change. Additionally, participants also reported feeling increased self-awareness and general improvement in relationships following their treatment.

Clinical Trials 98

Clinical Trials Research and Development Therapy Policy 98

Cannabis Law Report

SEPTEMBER 9, 2021

The current public policies in local and state cannabis ordinance and equity programs may enhance racial disparities if they follow the pattern of exclusion and criminalization that encompass past policies promoted as beneficial to African Americans but uphold racial capitalistic practices. Theme 3 involved access to capital.

Policy 105

Policy Research and Development Collective Banking 105

MMJ Recs

MARCH 16, 2024

With increasing acceptance of medical marijuana as a legitimate treatment option for various health conditions, the industry has attracted significant attention from investors, entrepreneurs, and policymakers alike. Policy decisions related to taxation, zoning, and advertising also impact the industry’s operations and growth trajectory.

Supply Chain 105

Supply Chain Research and Development Marijuana Seed-To-Sale 105

Cannabis Law Report

JUNE 23, 2021

Medicann is a premier cannabis-specialized clinic, providing patients with access to local specialist doctors and pharmacists that have experience prescribing cannabis-based medication. With a strong IP portfolio, RYAH gathers deep and insightful data on the complete patient session and formulation life cycle. About RYAH Group, Inc.

Programs 100

Programs Data Events Collective 100

Cannabis Law Report

JANUARY 12, 2022

Today, Maya (Maya PBC) and the National Psychedelics Association (NPA) announced their partnership in support of the implementation of Oregon’s Measure 109, the first state-approved policy to allow the regulated use of psilocybin products in a facilitated setting.

Research and Development 52

Research and Development Therapy Safety Clinical Trials 52

Cannabis Law Report

APRIL 12, 2019

Founded in 2014, Canadians for Fair Access to Medical Marijuana (CFAMM) (Canadiens pour l’accès équitable à la marijuana médicale (CAEMM)) is a federal non-partisan, non-profit, patient-run organisation dedicated to protecting and improving the rights of medical cannabis patients. million medical cannabis patients in Canada. About CFAMM.

Access 45

Access Patients Marijuana Medicine 45

United Patients Group

JUNE 8, 2023

It encourages patients to ask questions, provide accurate information, and participate in shared decision-making, leading to better treatment adherence and overall care quality. It replaces traditional paper-based forms and manual data entry, improving efficiency, accuracy, and patient experience. It also fosters active engagement.

Patients 52

Patients Data Collective Environment 52

SpeedWeed

AUGUST 22, 2021

The MS Society is taking a stand on the lack of progress and access to cannabis in the UK, especially since medical cannabis has been legal there for almost three years. deserves access to effective?treatments.” treatments.” . The organization’s report states that Sativex is only supported by 49 out of 106 CCGs.

Sleep 52

Sleep Access Patients Treatment 52

Cannabis Law Report

SEPTEMBER 28, 2021

The TGA has approved the use of MDMA and Psilocybin to treat mental illness in Australia by qualified medical professionals under a special access scheme. My ANIP host organisation (Johnathan Davis MLA’s office) may also use the data. If you withdraw no data from your response will be saved. Participant Information Sheet.

Therapy 52

Therapy Medicine Data Collective 52

CannaMD

SEPTEMBER 15, 2020

SHORT ANSWER: In November 2016, the Florida Medical Marijuana Legalization Initiative (known as Amendment 2 ) legalized medical marijuana treatment in Florida. In March, 2016, State Bill 307 expanded access to full-strength medical marijuana to terminally ill patients who were determined by two doctors to have less than a year to live.

Law 126

Law Marijuana Patients Treatment 126

Veriheal

AUGUST 9, 2023

Equally, 76% believed that addiction is preventable and treatable, underscoring the value of early intervention and treatment programs. Results showed that 58% of respondents were aware of naloxone, but only 35% reported that they would know where to access it in an emergency.

Education 98

Education Vaping Cannabis Consumption 98

Cannabis Law Report

NOVEMBER 29, 2021

A rational statewide drug policy requires that the coercive force of the criminal justice system be used constructively to influence far more people, numbering in the millions, than could ever be arrested, adjudicated, and sentenced.”. — Policy Recommendations. New Jersey spent $11.6 Executive Summary. “. billion to arrest people.

Policy 52

Policy Decriminalization Treatment History 52

Cannabis Law Report

APRIL 21, 2022

and Canada highlights mounting cases of cannabis poisoning among pets and sheds new light on symptoms, treatments, and outcomes. Richard Quansah Amissah of the Ontario Veterinary College at the University of Guelph in Ontario, Canada, and colleagues present these findings in the open-access journal PLOS ONE on April 20, 2022.

Pets 52

Pets Research and Development Topical Consumption 52

Cannabis Law Report

JANUARY 9, 2022

Since 2014 when sales began in Colorado and Washington, legalization policies have provided states a new revenue stream to bolster budgets and fund important services and programs. 7 Monthly excise tax data: [link] (for data prior to 2017); Monthly sales tax data and excise tax estimates based on sales volume provided here: [link].

Collective 52

Collective Policy Retail Programs 52

SpeedWeed

MARCH 13, 2021

However, common treatments do not address the non-motor symptoms and can sometimes cause side effects including dyskinesia, an abnormality or impairment of voluntary movement. . As a result, many patients turn to complementary or alternative treatments for their disease. . One such alternative treatment is cannabis.

Patients 52

Patients Treatment Therapy Sleep 52

CannaMD

APRIL 15, 2020

The National Organization for the Reform of Marijuana Laws (NORML) has issued marijuana policy guidance for lawmakers during the coronavirus (COVID-19) crisis, along with a statement regarding the designation of medical cannabis facilities as “essential.” NORML: COVID-19 Memo to Lawmakers.

Policy 55

Policy Patients Dispensary Banking 55

Cannabis Law Report

JUNE 15, 2021

. – Today, ahead of the 50th anniversary—on June 17—of when President Richard Nixon declared the “war on drugs,” Representatives Bonnie Watson Coleman (D-NJ) and Cori Bush (D-MO) unveiled the Drug Policy Reform Act (DPRA), alongside the Drug Policy Alliance, which has been a strategic partner on the development of the legislation.

Decriminalization 78

Decriminalization Policy Research and Development Data 78

SpeedWeed

APRIL 6, 2021

The use of cannabis by patients enrolled in a methadone maintenance treatment program is associated with fewer nonfatal opioid overdoses, according to the results of a recently published study. Patients were asked to complete a one-time survey, which included questions about their cannabis use over the past month.

Patients 52

Patients Advocacy Treatment Data 52

The Cannigma

AUGUST 24, 2021

Google announced in May, 2019 that they had updated their policy section of the Google to ban apps “that facilitate the sale of marijuana or maijruan products, regardless of legality.” Under the new Apple policy , an app must be submitted by a legal entity and geo-restricted to places where cannabis is legal.

Seed-To-Sale 111

Seed-To-Sale Research and Development Data Strains 111

Cannabis Law Report

NOVEMBER 19, 2021

MAPS PBC is pioneering a new form of mental health care, beginning with the development of MDMA-assisted therapy as an FDA-approved treatment for PTSD. MDMA-assisted therapy is a new paradigm in the treatment of mental health, combining a medicine with psychotherapy to address the root causes of PTSD. Position Requirements.

Research and Development 52

Research and Development Clinical Trials Therapy Pharmaceutical 52

Cannabis Law Report

NOVEMBER 14, 2019

Australia’s westernmost state is making it easier for patients to access medical cannabis. When considering many using medicinal cannabis products have serious illnesses and are sometimes financially strained, the previous access regime unnecessarily added a number of months and additional costs to the process.”

Patients 45

Patients Access Medicine Pharmaceutical 45

The Cannigma

JUNE 15, 2021

The first clinical research done on CBD as a potential treatment for epilepsy was in 1980, but the information gleaned didn’t make its way to the public eye until decades later. In other cases, CBDA products — or a mixture of CBD and CBDA — may be preferable, if for instance treatments with high doses of CBD have been unsuccessful for you.

CBD 122

CBD Research and Development Epilepsy Extraction 122

Cannabis Law Report

JANUARY 23, 2022

At current, transplant treatments are hindered by our understanding of the immune response of those receiving treatments. More than 25,000 hematopoietic stem cell transplantations (HSCTs) are performed each year for the treatment of lymphoma, leukemia, immune-de?ciency Many variables impact the outcomes of GVHD. Implications.

Research and Development 52

Research and Development Wellness and Beauty Patients CBD 52

Sensi Seeds

JANUARY 4, 2019

Since 2001, Canadians seeking to use cannabis for medical treatment have had access to it under the Marihuana Medical Access Regulations (MMAR ). It allows patients to have access to medicinal cannabis without danger of being criminalized. Context of the Medicinal Cannabis Situation.

Medicine 75

Medicine Research and Development Patients Programs 75

Cannabis Law Report

MAY 29, 2022

Widespread approval for psychedelic treatments remains unlikely, but the tide is slowly turning. In 2019, FDA approved Spravato (esketamine) nasal spray for treatment of depression in adults. [8] Schedule I controlled substances are the most restricted in terms of research, supply, and access, [13] and possession is criminalized.

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

Veriheal

DECEMBER 27, 2022

Researchers have taken a big step in understanding the connection between using psychedelics and feeling connected to nature in a study published in the journal Drug Science, Policy, and Law on Oct. The subjective nature of self-reported data can plague research. However, it does suggest a strong association between the two.

Research and Development 95

Research and Development Therapy Consumption DEA 95

Freedom Leaf

JANUARY 4, 2018

After months of development, my partner and I built and successfully launched the beta for our cannabis data-analytics software, Jade Insights. It’s a software platform that helps cannabis businesses augment their process by providing insights for data-backed decision-making. Policy Associate, Drug Policy Alliance , Washington, D.C.

Data 60

Data Policy Media Cannabis 60

Veriheal

OCTOBER 20, 2021

Veriheal does not support illegally consuming alternative therapeutic substances but acknowledges that it transpires because of the current illicit status, which we strive to change by advocating for research, legal access, and responsible consumption. Always consult a physician before attempting psychedelic therapy.

Therapy 98

Therapy Microdosing Decriminalization Consumption 98

Cannabis Law Report

JUNE 7, 2019

“Our drug-control policies are underpinned by evidence and research,” they said in a joint statement in February, adding that Singapore must continue to stay drug-free to prevent harm to its population and society. Cannabinoids are chemical compounds found in the cannabis plant.

Pharmaceutical 40

Pharmaceutical Cannabinoids Safety Data 40

Cannabis Law Report

JUNE 9, 2021

MAPS is committed to bringing these healing modalities to the world and providing them in such a way that communities that most need mental health resources have access to them. MAPS strives to continually improve upon the supportive, equitable, and accessible work environment. on the future of psychedelic-assisted psychotherapy.

Research and Development 76

Research and Development Compliance Compliance Education 76

Veriheal

MARCH 23, 2023

The people of Japan, a country renowned for its sushi cuisine scene, iconic Mount Fuji, and eye-catching cherry blossom trees, may soon have access to legal medicinal marijuana for intractable diseases. Data suggests that the market has inflated from JPY4 billion (USD$3 billion) in 2019 to JPY17 billion (USD$13 billion) in 2022.

Legalization 66

Legalization Marijuana Clinical Trials Seed-To-Sale 66

NORML

MAY 24, 2019

At the same time, the bill would redirect tax revenue from a legal industry towards various programs that redress harms from the War on Drugs, while also increasing and improving public education and treatment programs geared towards responsible use, reducing overdoses, and saving lives.

Marijuana 103

Marijuana Education Advocacy Legislation 103

Cannabis Law Report

JUNE 24, 2022

Minnesota; New Jersey; New York; Pennsylvania; and Washington all include provisions to give employees access to paid sick days and time off, as well as health insurance and retirement benefits. These gains, however, are not as accessible to minorities, who face barriers to entering the cannabis market.

Legislation 52

Legislation Cannabis Conditions Programs 52